Neurocrine To Acquire Soleno Therapeutics, Expanding Its Endocrinology And Rare Disease Portfolio

(MENAFN - PR Newswire) VYKATTM XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and Represents a Transformative Therapy Expands ...